1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
2 votes

Topics under Therapy

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 27000 reports

Global Dermatological Condition Statistics and Therapy Market

  • June 2017
    138 pages
  • Dermatological ...  

    Therapy  

    Transplantation  

  • World  

    United States  

View report >

Hormone and Therapy Market in Pakistan and the US

  • June 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Therapy Market in the US and Europe

  • June 2017
    11 pages
  • Therapy  

    Targeted Therap...  

  • United States  

    Europe  

View report >

Therapy Market and Hepatitis Statistics in the US and Asia

  • April 2017
    11 pages
  • Therapy  

    Hepatitis  

    Targeted Therap...  

  • United States  

    Asia  

View report >

Therapy Market in Japan - Forecast

  • April 2017
    9 pages
  • Therapy  

    Hospital  

  • Japan  

View report >

Therapy Market in France

  • April 2017
    5 pages
  • Therapy  

  • France  

View report >

Therapy Market in Germany

  • April 2017
    6 pages
  • Therapy  

  • Germany  

    Europe  

View report >

Glucagon Like Peptide 1 Receptor Activator and Therapy Market in Italy

  • November 2016
    11 pages
  • Glucagon Like P...  

    Therapy  

    Antidiabetics  

  • Italy  

View report >

Therapy Market and Monoclonal Antibody Market in the UK

  • June 2017
    39 pages
  • Therapy  

    Monoclonal Anti...  

  • United Kingdom  

View report >

Therapy Market and Heart Failure Statistics in Canada

  • May 2017
    7 pages
  • Therapy  

    Cardiovascular ...  

    Heart Failure  

  • Canada  

View report >


About 5800 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 75000)

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Cancer Diagnostics Market 2021: A 74-country Analysis-- ...

May 2017 $ 52400

Europe Clinical Chemistry Reagents And Analyzers Market ...

May 2017 $ 37500

Europe Cancer Diagnostics Market 2021: A 31-country Ana ...

May 2017 $ 36000

Immunodiagnostics 2021: Supplier Shares And Strategies, ...

March 2017 $ 23500

2017 Clinical Chemistry And Immunodiagnostic Analyzers ...

March 2017 $ 23500

2017 World Clinical Chemistry And Immunodiagnostics Mar ...

March 2017 $ 23500

Asia-pacific Clinical Chemistry Reagents And Analyzers ...

May 2017 $ 16500

Europe Cancer Diagnostics Market Analysis 2021: France, ...

June 2017 $ 12800

2017 Europe Cancer Diagnostics Market: Supplier Shares, ...

March 2017 $ 12800

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.